Table 4 Sensitivity analysis: estimated cost per quality-adjusted life years ($ per QALY) gained when other model parameters are varied.
From: An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas
Parameter varied in sensitivity analysis in addition to varying vaccine uptake rate | 50% increase females | 50% increase males and females |
|---|---|---|
Base case (vaccine cost = $178.14) | $126,689.20 | $94,517.75 |
Lower vaccination cost per dose (vaccine cost = $142.51) | $71,734.45 | $53,718.93 |
Higher vaccination cost per dose (vaccine cost = $217.11) | $194,065.98 | $144,497.70 |
Assuming no discount (vaccine cost = $178.14) | $182,489.66 | $124,332.14 |
Assuming no discount (vaccine cost = $142.51) | $103,726.46 | $70,802.06 |
Assuming no discount (vaccine cost = $217.11) | $279,060.27 | $189,923.46 |
Assuming no promotion cost (vaccine cost = $178.14) | − $1637.32 | − $219.39 |
Assuming no promotion cost (vaccine cost = $142.51) | − $1751.36 | − $614.05 |
Assuming no promotion cost (vaccine cost = $217.11) | − $1512.58 | $212.29 |
